Guilherme V. Baldo

Porto Alegre, RS 90035003, Brazil

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 104 publications

Oleoylethanolamide modulates fear memory even after rapamycin infusion into the hippocampus of male Wistar rats.

Oleoylethanolamide modulates fear memory even after rapamycin infusion into the hippocampus of male Wistar rats.

Journal: Neuropharmacology
Published: January 29, 2026

Liposomal CRISPR/Cas9-Mediated Local Genome Editing for Joint Disease in Mucopolysaccharidosis Type I.

Liposomal CRISPR/Cas9-Mediated Local Genome Editing for Joint Disease in Mucopolysaccharidosis Type I.

Journal: Pharmaceutics
Published: January 28, 2026

Genetic insights into the peoples who shaped the American continent.

Genetic insights into the peoples who shaped the American continent.

Journal: Genetics and molecular biology
Published: October 31, 2025

Unveiling Mucopolysaccharidosis IIIC in Brazil: Diagnostic Journey and Clinical Features of Brazilian Patients Identified Through the MPS Brazil Network.

Unveiling Mucopolysaccharidosis IIIC in Brazil: Diagnostic Journey and Clinical Features of Brazilian Patients Identified Through the MPS Brazil Network.

Journal: Diseases (Basel, Switzerland)
Published: October 28, 2025

Location matters for brain gene therapy in lysosomal disorders.

Location matters for brain gene therapy in lysosomal disorders.

Journal: Nature medicine
Published: August 19, 2025

Variant profile of Brazilian patients with Sanfilippo syndrome type B.

Variant profile of Brazilian patients with Sanfilippo syndrome type B.

Journal: Genetics and molecular biology
Published: August 15, 2025

Comprehensive Characterization of a Cluster of Mucopolysaccharidosis IIIB in Ecuador.

Comprehensive Characterization of a Cluster of Mucopolysaccharidosis IIIB in Ecuador.

Journal: Diagnostics (Basel, Switzerland)
Published: August 06, 2025

Recent Advances in Nose-to-Brain Gene Delivery for Central Nervous System Disorders.

Recent Advances in Nose-to-Brain Gene Delivery for Central Nervous System Disorders.

Journal: Pharmaceutics
Published: July 31, 2025

Molecular Profile of Mucopolysaccharidosis Type I Patients in Brazil.

Molecular Profile of Mucopolysaccharidosis Type I Patients in Brazil.

Journal: Journal of inherited metabolic disease
Published: June 17, 2025

Newborn Intravenous Injection of Liposomal CRISPR/Cas9 Complex Has No Incidence of Off-Targets or Tumors in Mice.

Newborn Intravenous Injection of Liposomal CRISPR/Cas9 Complex Has No Incidence of Off-Targets or Tumors in Mice.

Journal: Pharmaceutics
Published: April 10, 2025

Survey of Patients With Sanfilippo Type a (MPS IIIA) Disease Diagnosed by the MPS Brazil Network.

Survey of Patients With Sanfilippo Type a (MPS IIIA) Disease Diagnosed by the MPS Brazil Network.

Journal: American journal of medical genetics. Part A
Published: December 25, 2024

Disturbances in mitochondrial quality control and mitochondria-lysosome contact underlie the cerebral cortex and heart damage of mucopolysaccharidosis type II mice.

Disturbances in mitochondrial quality control and mitochondria-lysosome contact underlie the cerebral cortex and heart damage of mucopolysaccharidosis type II mice.

Journal: Metabolic brain disease
Published: October 21, 2024
Showing 1-12 of 104

Last Updated: 09/26/2026